About Alberto da Costa Stein
Form D filings for CellVax Therapeutics in 2024 list Alberto da Costa Stein as director.
Alberto da Costa Stein first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Alberto da Costa Stein in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Alberto da Costa Stein works with at each company, as listed on that company's latest Form D.
CellVax Therapeutics, Inc. · Form D, Oct 4, 2024
FK
Fernando Kreutz
Chief Executive Officer and director